B. Hédon

No ORCID on file · 16 papers in corpus · active 1987-2013

Study types

  • article 12
  • review 3
  • book-chapter 1

Condition tags

  • endometriosis 9
  • infertility 6
  • mesh:D004716 1
article 2013
Consensus on current management of endometriosis
Human Reproduction ·doi:10.1093/humrep/det050

STUDY QUESTION: Is there a global consensus on the management of endometriosis that considers the views of women with endometriosis? SUMMARY ANSWER: It was possible to produce an international consensus statement on the current management o…

article 2010
Fertilité des patientes présentant une endométriose traitées par cœlioscopie et AMP
Gynecologie, obstetrique & fertilite ·doi:10.1016/j.gyobfe.2010.08.018
article 2010
Place des techniques d’assistance médicale à la procréation
·doi:10.1016/s0368-2315(10)70034-x
review 2009
Endometriosis andin vitrofertilisation: A review
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology ·doi:10.3109/09513590903159599

This review aims to evaluate whether severe endometriosis has an impact on the outcome of in vitro fertilisation (IVF), whether IVF is associated with specific complications in this context, whether a specific ovarian stimulation protocol i…

review 2009
Endometriosis and in vitro fertilisation: A review
·doi:10.1080/09513590903159599

This review aims to evaluate whether severe endometriosis has an impact on the outcome of in vitro fertilisation (IVF), whether IVF is associated with specific complications in this context, whether a specific ovarian stimulation protocol i…

article 2009
Infertilité du couple : de l’interrogatoire à l’orientation thérapeutique
·doi:10.1016/s0368-2315(09)70227-3
article 2009
Local microenvironment of the human endometrial receptivity under COS: comparison between GnRH antagonist and agonist long protocols
·doi:10.1016/j.fertnstert.2009.07.1138
article 2008
GnRH agonist versus GnRH antagonist in women with endometriosis associated infertility
·doi:10.1016/j.fertnstert.2008.07.1135
article 2004
Equivalence of the 3-month and 28-day formulations of triptorelin with regard to achievement and maintenance of medical castration in women with endometriosis
Fertility and Sterility ·doi:10.1016/j.fertnstert.2003.07.013
article 2004
One year comparison between two add-back therapies in patients treated with a GnRH agonist for symptomatic endometriosis: a randomized double-blind trial
Human Reproduction ·doi:10.1093/humrep/deh250

BACKGROUND: It has been proposed that hormonal supplementation during prolonged GnRH agonist therapy prevents hypoestrogenic side effects, including bone loss. The optimal combination for long-term treatments with safe metabolic profile rem…

article 1998
Evaluation of Endometrial Inflammation by Quantification of Macrophages, T Lymphocytes, and Interleukin-1 and -6 in Human Endometrium
Journal of assisted reproduction and genetics ·doi:10.1023/a:1020337528607
article 1996
Endometrial cathepsin D immunostaining throughout ovulatory and anovulatory menstrual cycles
·doi:10.1093/humrep/11.2.392

The results of histological examination of the endometrium are normal in most patients with unexplained sterility. Cathepsin D is a ubiquitous lysosomal protease regulated by progesterone in the endometrium. Assays of concentrations of cath…

article 1996
Influence of age on results of infertility treatments
·doi:10.3109/09513599609116182
review 1990
10 The use of GnRH agonists with hMG for induction or stimulation of ovulation
·doi:10.1016/s0950-3552(05)80311-6
article 1987
Endometriosis and Medically Assisted Reproduction
Contributions to gynecology and obstetrics ·doi:10.1159/000414925
book-chapter 1987
Experience with Gestrinone Therapy in the Infertile Patient (Mild Endometriosis)
·doi:10.1159/000414874

During a one-year period (1985) 40 consecutive infertile patients for which mild endometriosis was diagnosed by laparoscopy were treated with gestrinone (Roussel-Uclaf, Paris, France), 2.5 mg twice a week, during 4 months. All these patient…